A Study of MR-Guided Laser Ablation of Prostate Bed Recurrences

Overview

About this study

The purpose of this study is to see if MR-guided laser ablation can effectively treat prostate tumor recurrences.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

This study has been withdrawn prior to enrollment

Inclusion Criteria

  • "Biopsy proven" soft tissue tumor recurrences of prostate fossa and referred to Urology and/or Interventional Radiology for treatment
  • Surgery is not a desirable alternative therapy at the time of enrollment
  • Radiation therapy has failed or not indicated or can be safely postponed
  • Tumor size ≤ 5 cm at its largest diameter
  • Tumor does not encompass the rectal wall or external urethral sphincter
  • Performance status is ECOG 2 or better in adults
  • Is able to undergo MRI

Exclusion Criteria

  • Has a pacemaker or defibrillator

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

David Woodrum, M.D., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20314520

Mayo Clinic Footer